Allergic asthma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Presenting with clinical symptoms such as wheezing, shortness of breath, chest tightness, and coughing; (2) Meeting the diagnostic criteria for mild to moderate asthma according to the classification standards; (3) Of any gender, aged 18 to 65 years, with good mental status, able to cooperate with treatment and examinations, and capable of objectively and accurately expressing the treatment outcomes; (4) Having not participated in any other clinical study within the past month; (5) Willing to cooperate voluntarily and having signed the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients with mild or severe acute exacerbations of allergic asthma, as well as those in the chronic persistent phase; (2) Patients with a confirmed history of respiratory system diseases affecting lung function, including pneumonia, pulmonary tuberculosis, lung abscess, and other pulmonary infectious diseases; bronchiectasis, chronic bronchitis, chronic obstructive pulmonary disease (COPD), and other airway diseases; (3) Patients with incomplete case records; (4) Patients with mental disorders; (5) Patients with severe cardiovascular, cerebrovascular, immune system diseases, or malignant tumors; (6) Patients who have participated in another clinical trial or received treatment for respiratory system diseases within the past 12 weeks; (7) Patients with contagious skin diseases or skin damage in the treatment area; (8) Pregnant women, breastfeeding women, or those suspected of being pregnant; (9) Patients with a fear of needles or a history of fainting due to needles.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma Control Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| SF-36;PFT; | — |
Countries
China
Contacts
Shanxi University of Traditional Chinese Medicine